|
JP4125790B2
(ja)
*
|
1996-12-20 |
2008-07-30 |
アストラゼネカ・アクチエボラーグ |
トリアゾロ［４，５−ｄ］ピリミジニル誘導体および医薬としてのその使用
|
|
SE9702772D0
(sv)
*
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
|
SE9702773D0
(sv)
*
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
|
SE9702774D0
(sv)
*
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
|
TW530058B
(en)
*
|
1997-07-22 |
2003-05-01 |
Astra Pharma Prod |
Triazolo [4,5-d]pyrimidine compounos and their use and process for preparation
|
|
DE69905451T2
(de)
*
|
1998-02-17 |
2003-11-20 |
Astrazeneca Uk Ltd., London |
Neue triazolo(4,5d) pyrimidinverbindungen
|
|
SE9802574D0
(sv)
*
|
1998-07-17 |
1998-07-17 |
Astra Pharma Prod |
Novel compounds
|
|
TWI229674B
(en)
*
|
1998-12-04 |
2005-03-21 |
Astra Pharma Prod |
Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
|
|
SE9904129D0
(sv)
*
|
1999-11-15 |
1999-11-15 |
Astra Pharma Prod |
Novel compounds
|
|
SE9904128D0
(sv)
*
|
1999-11-15 |
1999-11-15 |
Astra Pharma Prod |
Novel compounds
|
|
SE9904377D0
(sv)
*
|
1999-12-01 |
1999-12-01 |
Astra Pharma Prod |
Pharmaceutical combinations
|
|
GB0013488D0
(en)
|
2000-06-02 |
2000-07-26 |
Astrazeneca Ab |
Chemical compound
|
|
GB0013407D0
(en)
*
|
2000-06-02 |
2000-07-26 |
Astrazeneca Ab |
Forms of a chemical compound
|
|
US7018985B1
(en)
|
2000-08-21 |
2006-03-28 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
US7452870B2
(en)
*
|
2000-08-21 |
2008-11-18 |
Inspire Pharmaceuticals, Inc. |
Drug-eluting stents coated with P2Y12 receptor antagonist compound
|
|
AR039558A1
(es)
*
|
2000-08-21 |
2005-02-23 |
Inspire Pharmaceuticals Inc |
Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
|
|
US7132408B2
(en)
*
|
2000-08-21 |
2006-11-07 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
US6897201B2
(en)
*
|
2000-08-21 |
2005-05-24 |
Inspire Pharmaceuticals, Inc. |
Compositions and methods for the treatment of glaucoma or ocular hypertension
|
|
US7115585B2
(en)
*
|
2000-08-21 |
2006-10-03 |
Inspire Pharmaceuticals, Inc. |
Compositions for treating epithelial and retinal tissue diseases
|
|
GB0100624D0
(en)
*
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds VII
|
|
SE0101932D0
(sv)
*
|
2001-05-31 |
2001-05-31 |
Astrazeneca Ab |
Pharmaceutical combinations
|
|
US20020169730A1
(en)
*
|
2001-08-29 |
2002-11-14 |
Emmanuel Lazaridis |
Methods for classifying objects and identifying latent classes
|
|
US7435724B2
(en)
|
2002-02-27 |
2008-10-14 |
Inspire Pharmaceutical, Inc. |
Degradation-resistant mononucleoside phosphate compounds
|
|
DE602004018637D1
(de)
*
|
2003-04-09 |
2009-02-05 |
Biogen Idec Inc |
A2a-adenosinrezeptorantagonisten
|
|
EP1615930A2
(en)
*
|
2003-04-09 |
2006-01-18 |
Biogen Idec MA, Inc. |
Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagonists
|
|
EP1618108A2
(en)
*
|
2003-04-09 |
2006-01-25 |
Biogen Idec MA Inc. |
Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosine receptor antagonists
|
|
WO2004092177A1
(en)
*
|
2003-04-09 |
2004-10-28 |
Biogen Idec Ma Inc. |
Triazolopyrazines and methods of making and using the same
|
|
EP1618109A2
(en)
*
|
2003-04-09 |
2006-01-25 |
Biogen Idec MA Inc. |
Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists
|
|
GB2422782A
(en)
*
|
2003-10-21 |
2006-08-09 |
Inspire Pharmaceuticals Inc |
Non-nucleotide compositions and method for treating pain
|
|
US7749981B2
(en)
*
|
2003-10-21 |
2010-07-06 |
Inspire Pharmaceuticals, Inc. |
Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
|
|
US7335648B2
(en)
*
|
2003-10-21 |
2008-02-26 |
Inspire Pharmaceuticals, Inc. |
Non-nucleotide composition and method for inhibiting platelet aggregation
|
|
EP1685135B1
(en)
*
|
2003-10-21 |
2010-05-26 |
Inspire Pharmaceuticals, Inc. |
TETRAHYDRO-FURO[3,4-d]DIOXOLE COMPOUNDS AND COMPOSITIONS AND METHOD FOR INHIBITING PLATELET AGGREGATION
|
|
US7504497B2
(en)
*
|
2003-10-21 |
2009-03-17 |
Inspire Pharmaceuticals, Inc. |
Orally bioavailable compounds and methods for inhibiting platelet aggregation
|
|
US7932376B2
(en)
*
|
2005-05-05 |
2011-04-26 |
Inspire Pharmaceuticals, Inc. |
Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
|
|
WO2008054795A2
(en)
*
|
2006-10-31 |
2008-05-08 |
Janssen Pharmaceutica, N.V. |
Triazolopyrimidine derivatives as adp p2y12 receptor antagonists
|
|
UA100864C2
(uk)
*
|
2007-12-03 |
2013-02-11 |
Астразенека Аб |
Спосіб лікування або запобігання аневризмі черевної аорти
|
|
GB0906579D0
(en)
|
2009-04-16 |
2009-05-20 |
Vernalis R&D Ltd |
Pharmaceuticals, compositions and methods of making and using the same
|
|
JP5654990B2
(ja)
*
|
2008-08-20 |
2015-01-14 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
アゾ置換ピリジンおよびピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
|
|
US8859769B2
(en)
|
2010-02-16 |
2014-10-14 |
Actavis Group Ptc Ehf |
Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
|
|
BR112014013085A2
(pt)
|
2011-11-30 |
2017-06-13 |
Actavis Group Ptc Ehf |
forma cristalina do ticagrelor, processo para a preparação da forma cristalina do ticagrelor, composição farmacêutica e processo para preparar uma composição farmacêutica
|
|
WO2014083139A1
(en)
|
2012-11-29 |
2014-06-05 |
Actavis Group Ptc Ehf |
Novel amorphous form of ticagrelor
|
|
WO2014206187A1
(zh)
|
2013-06-24 |
2014-12-31 |
苏州明锐医药科技有限公司 |
替卡格雷及其中间体的制备方法
|
|
WO2014206188A1
(zh)
*
|
2013-06-27 |
2014-12-31 |
苏州明锐医药科技有限公司 |
替格瑞洛的制备方法
|
|
CN105061431B
(zh)
*
|
2015-07-28 |
2017-03-29 |
山东百诺医药股份有限公司 |
6‑n‑（2‑（甲硫基）乙基）‑2‑（（3,3,3‑三氟丙基）硫代）‑9h‑嘌呤及其制备方法和应用
|
|
CN112915063B
(zh)
*
|
2021-01-25 |
2022-12-20 |
刘红枚 |
一种用于治疗子宫平滑肌高频率强直性收缩相关疾病的化合物
|
|
CN112876485A
(zh)
*
|
2021-01-25 |
2021-06-01 |
郭丽伟 |
一种用于治疗子宫平滑肌高频率强直性收缩相关疾病的化合物
|
|
RU2770405C1
(ru)
*
|
2021-07-05 |
2022-04-15 |
федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации |
Производные триазола, проявляющие антиагрегационную активность
|